Merck & Co., Inc. and Schering-Plough Corporation have agreed to merge under the name Merck in a cash and stock transaction worth $41.1 billion. Merck Chairman, President and CEO Richard T. Clark will lead the new drug conglomerate. Also, Ford Motor Co. has announced a restructuring in the form of a swap offer in attempts to retire $10.4 billion in debt.
4 minute read